» Authors » James Tonkin

James Tonkin

Explore the profile of James Tonkin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 261
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Conway F, Tana A, Caneja C, Tonkin J, Avanzi L, Garner J, et al.
iScience . 2025 Mar; 28(3):111653. PMID: 40060899
Medical procedures often require proctoring that is traditionally done face-to-face, but this poses a significant carbon footprint and logistical challenges. Little is known about the safety and efficacy of remote...
2.
Smesseim I, Morin-Thibault L, Herth F, Tonkin J, Shah P, Slebos D, et al.
Respiration . 2024 Jun; 103(9):544-562. PMID: 38870914
Introduction: Persistent air leak (PAL) is associated with prolonged hospitalization, high morbidity and increased treatment costs. Conservative treatment consists of observation, chest tube drainage, and pleurodesis. Guidelines recommend surgical evaluation...
3.
Philip K, Buttery S, Bowen S, Lewis A, Jeffery E, Alghamdi S, et al.
BMJ Open Respir Res . 2024 May; 11(1). PMID: 38697677
Background: Singing for lung health (SLH) is an arts-based breathing control and movement intervention for people with long-term respiratory conditions, intended to improve symptoms and quality of life. Online, remotely...
4.
Raby K, Michaeloudes C, Tonkin J, Chung K, Bhavsar P
Front Immunol . 2023 Jul; 14:1201658. PMID: 37520564
The airway epithelium comprises of different cell types and acts as a physical barrier preventing pathogens, including inhaled particles and microbes, from entering the lungs. Goblet cells and submucosal glands...
5.
Shah P, Orton C, Grinsztejn B, Donaldson G, Crabtree Ramirez B, Tonkin J, et al.
Lancet Respir Med . 2022 Dec; 11(5):415-424. PMID: 36528039
Background: COVID-19 has overwhelmed health services globally. Oral antiviral therapies are licensed worldwide, but indications and efficacy rates vary. We aimed to evaluate the safety and efficacy of oral favipiravir...
6.
Conway F, Tonkin J, Valipour A, Pison C, Schumann C, Bonta P, et al.
Respiration . 2022 Oct; 101(11):1069-1074. PMID: 36302345
Background: Targeted Lung Denervation (TLD) is a potential new therapy for COPD. Radiofrequency energy is bronchoscopically delivered to the airways to disrupt pulmonary parasympathetic nerves, to reduce bronchoconstriction, mucus hypersecretion,...
7.
Tonkin J, Shah P
Respirology . 2022 Sep; 27(12):1012-1014. PMID: 36104311
No abstract available.
8.
Vijayakumar B, Boustani K, Ogger P, Papadaki A, Tonkin J, Orton C, et al.
Immunity . 2022 Feb; 55(3):542-556.e5. PMID: 35151371
Some patients hospitalized with acute COVID-19 suffer respiratory symptoms that persist for many months. We delineated the immune-proteomic landscape in the airways and peripheral blood of healthy controls and post-COVID-19...
9.
Philip K, Buttery S, Williams P, Vijayakumar B, Tonkin J, Cumella A, et al.
BMJ Open Respir Res . 2022 Jan; 9(1). PMID: 35027428
Introduction: The impact of acute COVID-19 on people with asthma appears complex, being moderated by multiple interacting disease-specific, demographic and environmental factors. Research regarding longer-term effects in this group is...
10.
Oldham J, Lee C, Wu Z, Bowman W, Pugashetti J, Dao N, et al.
Eur Respir J . 2021 Nov; 59(6). PMID: 34737223
Background: Proposed criteria for progressive fibrosing interstitial lung disease (PF-ILD) have been linked to increased mortality risk, but lung function trajectory after satisfying individual criteria remains unknown. Because survival is...